Valiant Laboratories
VALIANTLAB · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 6, 2023

Stock Price vs Company Growth
1d
2.2%
1w
3.7%
1m
2.1%
3m
6.2%
6m
24.3%
1y
38.1%
all
29.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 116 2.2%
99.9
135
Company Overview

Sales
150 Cr
Growth: -36.9%
Profit after Tax
-4.46 Cr
Growth: -1493.1%
Small Cap
505 Cr
P/S: 3.4x
Industry P/S: 3.3x
Fundamentals

Sales (Cr) ₹ 150
Growth -36.9%
EBITDA -9.8%
P/S 3.4x
Dividend 0.0%
P/E -113.9x
Book Value ₹ 10
PEG Ratio 3.1x
ROE -10.9%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Valiant Laboratories is a leading Active Pharmaceutical ingredient manufacturing company with its focus on manufacturing Paracetamol API/Bulk Drug which has several applications like uses in treatment of conditions such as headache, muscle ache, arthritis, back ache, toothache, cold and fever. Key events and milestones1980: Formed Bharat Chemicals (a partnership firm).1981: Acquired plot No.
Belongs to (1 Indices)